Tag: results

SOUTH SAN FRANCISCO, Calif., June 13, 2025 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”, “Company”), a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases, today announced that the Compensation Committee of the Company’s Board of Directors granted non-qualified stock options to purchase an aggregate of 26,000 shares of the Company’s stock (the “Inducement Grant”) to newly hired employees on June 10, 2025 (the “Grant Date”), in connection with the commencement of employment.

CALGARY, Alberta, June 13, 2025 (GLOBE NEWSWIRE) -- Peyto Exploration & Development Corp. (TSX: PEY) ("Peyto") announces the retirement of Michael (Mick) MacBean as a director and confirms the monthly dividend with respect to June 2025 of $0.11 per common share is to be paid on July 15, 2025, for shareholders of record on June 30, 2025. Dividends paid by Peyto to Canadian residents are eligible dividends for Canadian income tax purposes.

WEST PALM BEACH, Fla., June 13, 2025 (GLOBE NEWSWIRE) -- Sunrise Realty Trust, Inc. (Nasdaq: SUNS) (“SUNS”), a lender on the TCG Real Estate platform, today announced its dividend for the quarter ending June 30, 2025.

HOUSTON and LONDON, June 13, 2025 (GLOBE NEWSWIRE) -- Baker Hughes (NASDAQ: BKR) will announce the results of the second quarter ending June 30, 2025, via press release at 5 p.m. Eastern Time (4 p.m. Central Time) on Tuesday, July 22, 2025. A webcast to discuss the results will be held Wednesday, July 23, at 9:30 a.m. Eastern Time (8:30 a.m. Central Time).

MIAMI, June 13, 2025 (GLOBE NEWSWIRE) -- AYR Wellness Inc. (CSE: AYR.A, OTCQX: AYRWF) (“AYR” or the “Company”), a leading vertically integrated U.S. multi-state cannabis operator, announces that it has not completed the filing of its interim financial statements, management’s discussion and analysis, and related CEO and CFO certificates for the three-month period ended March 31, 2025 (collectively, the “Interim Filings”) by the previously anticipated date of June 13, 2025.‎

New clinical results show sustained CRi, deep bone marrow responses, and encouraging survival in FLT3-mutant AML patients, including those previously treated with gilteritinib

Singapore, June 13, 2025 (GLOBE NEWSWIRE) -- Springview Holdings Ltd (Nasdaq: SPHL) (“Springview Holdings”, or the “Company”), a leading designer and builder of residential and commercial properties in Singapore, today announced that its indirect wholly owned Singapore operating subsidiary, Springview Enterprises Pte. Ltd. (“Springview Singapore”) has been officially awarded bizSAFE Level 4 certification by the Workplace Safety and Health Council, effective June 9, 2025. This milestone marks a major leap forward in Springview Singapore’s journey toward operational excellence and sustainable growth.